Incidence and imaging characteristics of skeletal metastases detected by bone scintigraphy in lung cancer patients
نویسندگان
چکیده
منابع مشابه
[Incidence and imaging characteristics of skeletal metastases detected by bone scintigraphy in lung cancer patients].
BACKGROUND/AIM Detection of metastatic bone disease by skeletal scintigraphy is a classical application of nuclear medicine in cancer patients. Detection of bone metastases in patients with lung cancer is necessary for an appropriate treatment modality. The aim of this study was to report the frequency and imaging characteristics of bone metastases detected by bone scintigraphy (BS) using techn...
متن کاملIncidence and consequences of bone metastases in lung cancer patients
BACKGROUND Bone metastases (BM) are common in NSCLC patients. Despite some potential positive effects of bone-targeted therapies, their use in NSCLC is infrequent, which may relate to the overall poor prognosis of advanced lung cancer. We reviewed the literature to evaluate the incidence, consequences and use of bone-targeting agents in lung cancer patients with BM in both the trial and non-tri...
متن کاملBone Metastases Detection by 18F-FDG PET/CT Versus 99mTc Bone Scintigraphy (Planar and SPECT) in Patients with Lung Cancer
Detection of bone metastases in patients with lung cancer has important clinical significance and therapeutic implications, since it causes relevant changes in the patients’ treatment. This study compared the efficacies of 18F-fludeoxyglucose positron emission tomography (18F-FDG PET)/CT, and 99mTc bone scintigraphy [planar and single photon emission CT (SPECT))for detection of bone metastases ...
متن کاملAdditive clinical value of bone scintigraphy in patients with malignant tumors with absence of localized bone pain: A report on most common sex-related cancers
Introduction: Almost all malignant tumors have the potential to eventually produce bone metastasis. The aim of the current study was to report the distribution pattern and imaging characteristics of bone metastases detected by conventional whole body bone scintigraphy in patients with different types of malignancies and to assess their relationship with the complain...
متن کاملIntravenous ibandronate reduces the incidence of skeletal complications in patients with breast cancer and bone metastases.
BACKGROUND This phase III study compared the efficacy of the new potent bisphosphonate, ibandronate, with placebo as intravenous (i.v.) therapy in metastatic bone disease due to breast cancer. PATIENTS AND METHODS A total of 466 patients were randomised to receive placebo (n = 158), or 2 mg (n = 154) or 6 mg (n = 154) ibandronate every 3-4 weeks for up to 2 years. The primary efficacy paramet...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Military Medical and Pharmaceutical Journal of Serbia
سال: 2006
ISSN: 0042-8450,2406-0720
DOI: 10.2298/vsp0612001j